Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fight Retinal Blindness SPAIN. Report 3: clinical outcomes of vascular endothelial growth factor inhibitors in low vision eyes with neovascular age-related macular degeneration. A national database study.
Puzo M, Calvo-Perez P, Bartol-Puyal F, Sanchez-Monroy J, Martin-Pinardel R, Parrado-Carrillo A, Moll-Udina A, Bernal-Morales C, Sanchez-Vela L, Sararols-Ramsay L, Garay-Aramburu G, Arruabarrena C, García-Arumí J, Abraldes M, Ruiz-Moreno JM, Valldeperas X, Velázquez-Villoria D, Escobar-Barranco JJ, Gallego-Pinazo R, Figueroa MS, Figueras-Roca M, Barthelmes D, Gillies MC, Casaroli-Marano RP, Zarranz-Ventura J; from the writing committee of the Fight Retinal Blindness Spain (FRB! Spain) Users Group. Puzo M, et al. Among authors: garcia arumi j. Eye (Lond). 2024 Dec;38(18):3450-3458. doi: 10.1038/s41433-024-03322-8. Epub 2024 Sep 21. Eye (Lond). 2024. PMID: 39306616
Predicting proliferative vitreoretinopathy: temporal and external validation of models based on genetic and clinical variables.
Rojas J, Fernandez I, Pastor JC, MacLaren RE, Ramkissoon Y, Harsum S, Charteris DG, Van Meurs JC, Amarakoon S, Garcia-Arumi J, Ruiz-Moreno JM, Rocha-Sousa A, Brion M, Carracedo A; Genetics on PVR Study Group (web file). Rojas J, et al. Br J Ophthalmol. 2015 Jan;99(1):41-8. doi: 10.1136/bjophthalmol-2014-305263. Epub 2014 Jul 29. Br J Ophthalmol. 2015. PMID: 25075124
A genetic case-control study confirms the implication of SMAD7 and TNF locus in the development of proliferative vitreoretinopathy.
Rojas J, Fernandez I, Pastor JC, Maclaren RE, Ramkissoon Y, Harsum S, Charteris DG, Van Meurs JC, Amarakoon S, Ruiz-Moreno JM, Rocha-Sousa A, Brion M, Carracedo A; Genetics on PVR Study Group. Rojas J, et al. Invest Ophthalmol Vis Sci. 2013 Mar 5;54(3):1665-78. doi: 10.1167/iovs.12-10931. Invest Ophthalmol Vis Sci. 2013. PMID: 23258148
Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.
Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM; OZURDEX GENEVA Study Group. Haller JA, et al. Ophthalmology. 2010 Jun;117(6):1134-1146.e3. doi: 10.1016/j.ophtha.2010.03.032. Epub 2010 Apr 24. Ophthalmology. 2010. PMID: 20417567 Clinical Trial.
Optical coherence tomography biomarkers in MYO7A-inherited retinal dystrophy: longitudinal study in pediatric patients.
Subirà O, Català-Mora J, Del Prado C, Díaz-Cascajosa J, Barraso Rodrigo M, Cobos E, Aguilera C, Esteve-Garcia A, García-Arumí J, Caminal JM. Subirà O, et al. Among authors: garcia arumi j. Graefes Arch Clin Exp Ophthalmol. 2024 Oct;262(10):3375-3384. doi: 10.1007/s00417-024-06545-3. Epub 2024 Jun 13. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 38871877
188 results